Major Shareholders

The Articles of the Association of Ablynx NV provide for shareholders notification threshold of 3%, 5% or a multiple of 5% (i.e. 10%, 15%, 20% etc) of the total number of existing voting rights.

The notification forms can be downloaded from the website of the FSMA. Completed and signed forms should be sent to investors@ablynx.com.

The table below provides an overview of transparency notifications received to date:

DatePress releaseNotification forms
2018/05/21

21 May 2018

BlackRock, Inc.

2018/05/11

11 May 2018

BlackRock, Inc.

2018/05/08

8 May 2018

BlackRock, Inc.
- 2 May 2018
- 3 May 2018

2018/05/03

3 May 2018

UBS Group AG
- 24 April 2018
- 26 April 2018

2018/04/30

30 Apr 2018

UBS Group AG
- 20 April 2018
- 23 April 2018

2018/04/24

24 Apr 2018

UBS Group AG
- 12 April 2018
- 13 April 2018

2018/04/19

19 Apr 2018

Bank of America Corporation

2018/04/19

19 Apr 2018

BlackRock, Inc.

2018/04/17

17 Apr 2018

BlackRock, Inc.
- 9 April 2018
- 12 April 2018

2018/04/12

12 Apr 2018

UBS Group AG

2018/04/12

12 Apr 2018

BlackRock, Inc.

2018/04/10

10 Apr 2018

BlackRock, Inc.
- 5 April 2018
- 9 April 2018

2018/04/10

10 Apr 2018

Davidson Kempner Capital Management LLP
- 13 February 2018
- 4 April 2018

2018/04/06

6 Apr 2018

UBS Group AG
- 28 March 2018
- 29 March 2018

2018/04/05

5 Apr 2018

Baker Bros. Advisors LP

2018/04/05

5 Apr 2018

FMR LLC

2018/03/28

28 Mar 2018

BlackRock, Inc.

2018/03/26

26 Mar 2018

BlackRock, Inc.

2018/03/22

22 Mar 2018

Bank of America Corporation

2018/03/21

21 Mar 2018

Van Herk Investments B.V.

2018/03/20

20 March 2018

Baker Bros. Advisors LP

2018/03/12

12 March 2018

BlackRock, Inc.

2018/03/09

9 Mar 2018

FMR LLC
- 6 March 2018
- 7 March 2018 (1)
- 7 March 2018 (2)

2018/02/28

28 Feb 2018

BlackRock, Inc.

2018/02/15

15 Feb 2018

Van Herk Investments B.V.

2018/02/15

15 Feb 2018

Davidson Kempner Capital Management LLP

2018/02/12

12 Feb 2018

FMR LLC
- 7 February 2018
- 8 February 2018

2018/02/12

12 Feb 2018

BlackRock, Inc.

2018/02/07

7 feb 2018

Bank of America Corporation

2018/02/07

7 feb 2018

Norges Bank
- 1 February 2018
- 2 February 2018

2018/02/06

6 Feb 2018

FMR LLC

2018/02/06

6 Feb 2018

Bank of America Corporation

2018/02/05

5 Feb 2018

Marshall Wace LLP
- 26 January 2019
- 29 January 2018

2018/02/05

5 Feb 2018

FMR LLC

2018/02/02

2 Feb 2018

Consonance CapMan GP LLC

2018/01/18

18 Jan 2018

FMR LLC
- 16 January 2018
- 17 January 2018

2018/01/18

18 Jan 2018

Bank of America Corporation
- 15 January 2018
- 16 January 2018

2018/01/16

16 Jan 2018

Van Herk Investments B.V.

2018/01/16

16 Jan 2018

Marshall Wace LLP

2018/01/10

10 Jan 2018

Consonance CapMan GP LLC

2017/11/29

29 Nov 2017

Millennium Group Management LLC

2017/11/15

15 Nov 2017

Perceptive Advisors LLC

2017/11/15

15 Nov 2017

C.H. Boehringer Sohn AG & Co KG

2017/11/10

10 Nov 2017

Millennium Group Management LLC

2017/11/07

7 Nov 2017

Bank of America Corporation

2017/11/07

7 Nov 2017

Farallon Capital Management LLC

2017/11/03

3 Nov 2017

Millennium Group Management LLC 1 Nov 2017

Millennium Group Management LLC 31 Oct 2017

2017/11/03

3 Nov 2017

Baker Bros. Advisors LP

2017/10/16

16 Oct 2017

Consonance CapMan GP LLC

2017/10/13

13 Oct 2017

Van Herk Investments B.V.

2017/10/06

6 Oct 2017

Consonance CapMan GP LLC

2017/08/30

30 Aug 2017

FMR LLC

2017/08/30

30 Aug 2017

Bank of America Corporation

2017/07/06

6 Jul 2017

Bank of America Corporation

2017/06/16

16 Jun 2017

FMR LLC

2017/01/24

24 Jan 2017

Van Herk Investments B.V.

2016/12/28

28 Dec 2016

FMR LLC

2016/12/23

23 Dec 2016

FMR LLC

2016/11/18

18 Nov 2016

FMR LLC

2016/10/11

11 Oct 2016

FMR LLC

2016/09/15

15 Sept 2016

Oppenheimer Funds, Inc.

2016/09/06

6 Sept 2016

GAM International and GAM Holding

Taube Hodson Stonex Partners

2016/08/12

12 Aug 2016

Van Herk Investments B.V.

2016/08/04

4 Aug 2016

Bank of America Corporation

2016/06/16

16 June 2016

Adrianus Van Herk

2016/06/14

14 June 2016

JP Morgan Asset Management Holdings Inc.

2016/05/13

13 May 2016

 Polar Capital Funds Plc

2016/03/14

14 March 2016

Aviva plc and Aviva Investors Global Services

2016/03/07

7 March 2016

Abingworth Management Limited and Abingworth LLP

2016/01/18

18 Jan 2016

Perceptive Advisors LLC

2016/01/05

 5 Jan 2016

 Abingworth Management Limited and Abingworth LLP

2015/12/22

 22 Dec 2015 

 Abingworth Management Limited and Abingworth LLP

2015/12/02

 2 Dec 2015

 JP Morgan Asset Management Holdings Inc. and JP Morgan Asset Management (UK) Limited

2015/12/01

 1 Dec 2015

 Aviva plc and Aviva Investors Global Services

2015/08/14

14 Aug 2015

 Abingworth Management Limited and Abingworth LLP

2015/07/29

29 July 2015

Taube Hodson Stonex Partners LLP

2015/07/14

14 July 2015

Oppenheimer Funds, Inc.

2015/07/01

1 July 2015

Taube Hodson Stonex Partners LLP

2015/05/26

26 May 2015

 FMR LLC

2015/05/22

22 May 2015

 Taube Hodson Stonex Partners LLP

2015/04/15

15 April 2015

 FMR LLC

2015/03/16

16 March 2015

 Polar Capital Funds plc and FMR

2015/03/03

3 March 2015

Aviva plc and Aviva Investors Global Services

2014/12/24

24 Dec 2014

Biotech Value Fund Partners LP (BVF Partners LP) and Biotech Value Fund Inc (BVF Inc)

2014/07/08

8 July 2014

Fidelity Management Research LLC

2014/05/20

20 May 2014

Biotech Value Fund Partners LP (BVF Partners LP) and Biotech Value Fund Inc (BVF Inc)

2014/04/30

30 April 2014

Abingworth Management Limited and Abingworth LLP

2013/12/05

5 Dec 2013

Perceptive Advisors LLP

2013/11/25

25 Nov 2013

Biotech Value Fund Partners LP (BVF Partners LP) and Biotech Value Fund Inc (BVF Inc)

Sofinnova Partners SAS

2013/10/30

30 Oct 2013

Aviva Investors Global Services Limited

2013/10/18

18 Oct 2013

Gimv NV and Biotech Fonds Vlaanderen NV

2013/10/01

1 Oct 2013

Gimv NV and Biotech Fonds Vlaanderen NV

2013/09/30

30 Sept 2013

Biotech Value Fund Partners LP (BVF Partners LP) and Biotech Value Fund Inc (BVF Inc)

2013/08/27

27 Aug 2013

Gimv NV – Adviesbeheer Gimv Life Sciences 2004 NV and Biotech Fonds Vlaanderen NV

2013/05/08

8 May 2013

KBC Asset Management NV

2013/04/17

17 April 2013

KBC Asset Management NV
2013/03/08

8 March 2013

Gimv NV – Adviesbeheer Gimv Life Sciences NV – Adviesbeheer Gimv Life Sciences 2004 NV and Biotech Fonds Vlaanderen NV

Sofinnova Partners SAS

2012/12/14

14 Dec 2012

Alta Partners (ACP IV, LP.)

2012/10/23

23 Oct 2012

Sofinnova Partners SAS

Gilde Europe Food & Agribusiness Fund BV

2012/10/22

22 Oct 2012

KBC Group NV and KBC Private Equity NV

2012/10/08

8 Oct 2012

Gilde Europe Food & Agribusiness Fund BV

2012/04/27

27 April 2012

VIB VZW

2011/12/23

23 Dec 2011

Alta Partners (ACP IV, LP.)

2011/12/09

9 Dec 2011

Multifund B.V., Nederlandia Investments B.V., Stichting Avivia

2011/11/29

29 Nov 2011

Multifund B.V., Nederlandia Investments B.V.

2010/04/23

23 April 2010

KBC Groep NV and KBC Private Equity NV

2010/03/18

25 March 2010

Gimv NV, Adviesbeheer Gimv Life Sciences NV Adviesbeheer Gimv Life Sciences 2004 NV and Biotech Fonds Vlaanderen NV

C.H.Boehringer Sohn AG & Co. KG and Boehringer Ingelheim International GmbH

Multifund B.V., Nederlandia Investments B.V. and Stichting Avivia, KBC Groep NV and KBC Private Equity NV

2009/09/24

24 Sept 2009

KBC Asset Management NV

2009/04/24

24 April 2009

Denominator Transparancy notification

2008/11/05

5 Nov 2008

Sofinnova Partners SAS

Abingworth Management Limited and Abingworth LLP

Alta California Partners IV, LP

Gilde Europe Food & Agribusiness

VIB VZW

KBC Asset Management NV